Ascend Laboratories amlodipine-olmesartan tablets recalled for substandard active ingredient

What this means

Ascend Laboratories is recalling one lot of amlodipine and olmesartan medoxomil combination tablets (10 mg/20 mg) because the olmesartan medoxomil active ingredient is below the required amount. This means affected tablets may not work as intended to lower blood pressure.

• Check if your amlodipine-olmesartan tablets are from lot 25121311 (expiration 3/31/2028).
• Contact your pharmacy or doctor if you have this lot — do not stop taking your blood pressure medication without medical guidance.
• Your pharmacist or doctor can provide a replacement or alternative medication.